Florian Lenze1, Chlodwig Kirchhoff2, Florian Pohlig3, Carolin Knebel3, Hans Rechl3, Birgit Marten-Mittag4, Peter Herschbach4,5, Rüdiger V Eisenhart-Rothe3, Ulrich Lenze3. 1. Department of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany Flo_Lenze@yahoo.de. 2. Department of Trauma Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 3. Department of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 4. Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany. 5. Roman Herzog Comprehensive Cancer Center, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Abstract
BACKGROUND/AIM: Psycho-oncological distress is a relevant clinical problem. The aim of this study was to administer a standardized psycho-oncological distress screening for early identification and indication-based treatment of highly distressed orthopedic cancer patients as well as the evaluation of distress patterns. PATIENTS AND METHODS: In total, 35 patients with cancer were psycho-oncologically screened using a cancer-specific expert rating scale (Basic Documentation for Psycho-Oncology Short Form) at three different time points (day of admission, day before discharge, 3 months postoperatively). Psycho-oncological support was offered to all patients whose distress exceeded a defined cut-off value. RESULTS: Levels of distress in approximately 51% of patients exceeded the cut-off value at the time of admission and these patients received psycho-oncological support. The high distress levels decreased significantly over time. Patients whose distress did not exceed the cut-off value at the first assessment showed low distress levels at all time points. CONCLUSION: A relevant number of orthopedic tumor patients suffer from psychosocial distress. Standardized screening might help to identify and adequately treat those patients. Copyright
BACKGROUND/AIM: Psycho-oncological distress is a relevant clinical problem. The aim of this study was to administer a standardized psycho-oncological distress screening for early identification and indication-based treatment of highly distressed orthopedic cancerpatients as well as the evaluation of distress patterns. PATIENTS AND METHODS: In total, 35 patients with cancer were psycho-oncologically screened using a cancer-specific expert rating scale (Basic Documentation for Psycho-Oncology Short Form) at three different time points (day of admission, day before discharge, 3 months postoperatively). Psycho-oncological support was offered to all patients whose distress exceeded a defined cut-off value. RESULTS: Levels of distress in approximately 51% of patients exceeded the cut-off value at the time of admission and these patients received psycho-oncological support. The high distress levels decreased significantly over time. Patients whose distress did not exceed the cut-off value at the first assessment showed low distress levels at all time points. CONCLUSION: A relevant number of orthopedic tumorpatients suffer from psychosocial distress. Standardized screening might help to identify and adequately treat those patients. Copyright
Authors: Michael J Griesser; Blake Gillette; Martha Crist; Xueliang Pan; Peter Muscarella; Thomas Scharschmidt; Joel Mayerson Journal: Am J Phys Med Rehabil Date: 2012-01 Impact factor: 2.159
Authors: Kristi D Graves; Susanne M Arnold; Celia L Love; Kenneth L Kirsh; Pamela G Moore; Steven D Passik Journal: Lung Cancer Date: 2006-11-03 Impact factor: 5.705
Authors: U Lenze; C Kirchhoff; K Book; F Pohlig; G Gradl; H Rechl; P Herschbach; R von Eisenhart-Rothe Journal: Orthopade Date: 2012-12 Impact factor: 1.087
Authors: William F Pirl; Anna Muriel; Vivian Hwang; Alice Kornblith; Joseph Greer; Karen Donelan; Donna B Greenberg; Jennifer Temel; Lidia Schapira Journal: J Support Oncol Date: 2007 Nov-Dec
Authors: L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz Journal: Br J Cancer Date: 2004-06-14 Impact factor: 7.640
Authors: Gary E Mason; Lele Aung; Sarah Gall; Paul A Meyers; Robert Butler; Sarah Krüg; Mimi Kim; John H Healey; Richard Gorlick Journal: Front Oncol Date: 2013-08-14 Impact factor: 6.244